A Promising Pilot Project for Multiple Sclerosis!

We're thrilled to announce that Ad Scientiam is launching the MS-FLOWER pilot project in the United States! Our goal? To evaluate the integration of our innovative medical device, MSCopilot®, into the routine care of patients with multiple sclerosis (MS).

Building on our collaboration with Sanofi in the MS-Detect trial, which has enrolled over 300 PwMS across the US, Canada, and Europe, we aim to enroll 100 patients across five leading US MS centers over the next six months.

Together, we'll explore how MSCopilot® can:

• Optimize disease management
• Improve real-time symptom monitoring
• Enhance engagement for both patients and healthcare professionals

Don’t miss all the details in our press release .